ArticleFrontiers in oncology2019

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.

Robert Frank Cornell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.